Stratasys Ltd 's

The company faces competitive challenges due to federal and state restrictions on non-competition agreements, which may affect its ability to retain key employees and impact its competitive position. It relies on management information systems for critical business functions, and any failure or interruption could adversely affect operations. The company depends on patent protection, trade secret protection, confidentiality agreements, and other contractual arrangements to maintain its competitive position. It has acquired companies and technologies including Origin and its P3 technology, RPS and its stereolithography technology, and Xaar and its powder-based SAF technology. In 2024, the company initiated patent infringement claims against Bambu Lab, with ongoing litigation and a trial scheduled for June 2026. The company also faces intellectual property challenges in patent tribunals, including oppositions at the European Patent Office and proceedings before the US Patent Trial & Appeal Board. There is a risk that patents may be challenged, invalidated, or circumvented, and enforcement of intellectual property rights can be costly and disruptive. The company uses confidentiality and invention assignment agreements to protect trade secrets and know-how, aiming to prevent competitors from developing consumables compatible with its printing systems; however, these agreements may be difficult to enforce or provide inadequate remedies if violated.